JDD Issue Highlights | June 2022: Acne & Rosacea
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP … Continue reading "JDD Issue Highlights | June 2022: Acne & Rosacea"
The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist … 
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris … 
During the 2021 ODAC Dermatology, Aesthetic and Surgical Conference held virtually on January 14th-17th, dermatologists from around the country submitted newly published research findings and novel therapeutics in the areas of acne and rosacea, all presented as part of a virtual scientific poster gallery. We share the highlights of each poster below!
Efficacy and Safety of Narrow-spectrum Oral … 
You are at the end of a busy afternoon clinic, with only a single patient standing between you and freedom to go visit a good friend and watch the Stanley Cup playoffs, of course after completing a metric ton of electronic charting. The chart in the door (or more likely on the EMR tablet) says “CHIEF COMPLAINT: ACNE”. Do you smile or groan? Acne vulgaris, or “common” acne, is itself among … 